Stocks and Investing Stocks and Investing
Thu, April 1, 2021
[ 12:00 AM ] - WOPRAI
Robert Drbul Maintained (AMZN) at Strong Buy on, Apr 1st, 2021
[ 12:00 AM ] - WOPRAI
Nigel Dally Maintained (UNM) at Hold with Increased Target to $28 on, Apr 1st, 2021
[ 12:00 AM ] - WOPRAI
Brent Thill Initiated (UBER) at Strong Buy and Held Target at $75 on, Apr 1st, 2021
[ 12:00 AM ] - WOPRAI
Sami Badri Maintained (UI) at Sell with Decreased Target to $126 on, Apr 1st, 2021
[ 12:00 AM ] - WOPRAI
Derrick Whitfield Downgraded (TPL) to Hold and Held Target at $453 on, Apr 1st, 2021
[ 12:00 AM ] - WOPRAI
Danielle Antalffy Maintained (TNDM) at Hold with Decreased Target to $95 on, Apr 1st, 2021
[ 12:00 AM ] - WOPRAI
Matthew Boss Maintained (TJX) at Buy with Increased Target to $74 on, Apr 1st, 2021
[ 12:00 AM ] - WOPRAI
Scott Berg Maintained (TYL) at Strong Buy with Decreased Target to $480 on, Apr 1st, 2021
[ 12:00 AM ] - WOPRAI
Mark Lipacis Maintained (TXN) at Strong Buy and Held Target at $206 on, Apr 1st, 2021
[ 12:00 AM ] - WOPRAI
Ryan Todd Maintained (TTE) at Buy with Increased Target to $60 on, Apr 1st, 2021
[ 12:00 AM ] - WOPRAI
Mark Miller Maintained (WDC) at Strong Buy and Held Target at $75 on, Apr 1st, 2021
[ 12:00 AM ] - WOPRAI
A.J. Rice Maintained (WBA) at Hold with Increased Target to $50 on, Apr 1st, 2021
[ 12:00 AM ] - WOPRAI
Betsy Graseck Maintained (AXP) at Buy with Increased Target to $166 on, Apr 1st, 2021
[ 12:00 AM ] - WOPRAI
Timothy Wojs Upgraded (AYI) to Buy and Increased Target to $190 on, Apr 1st, 2021
[ 12:00 AM ] - WOPRAI
John Walsh Maintained (AYI) at Buy with Increased Target to $186 on, Apr 1st, 2021
[ 12:00 AM ] - WOPRAI
Heiko Ihle Maintained (AG) at Strong Buy with Increased Target to $20 on, Apr 1st, 2021
[ 12:00 AM ] - WOPRAI
Joseph Pantginis Maintained (ATNM) at Strong Buy with Decreased Target to $57 on, Apr 1st, 2021
[ 12:00 AM ] - WOPRAI
Joseph Spak Maintained (TEL) at Buy and Held Target at $149 on, Apr 1st, 2021
[ 12:00 AM ] - WOPRAI
Bret Jordan Initiated (TEN) at Strong Buy and Held Target at $13 on, Apr 1st, 2021
[ 12:00 AM ] - WOPRAI
Geoffrey Porges Maintained (TBPH) at Buy with Decreased Target to $40 on, Apr 1st, 2021
[ 12:00 AM ] - WOPRAI
Kevin Mcveigh Maintained (WSC) at Buy with Increased Target to $35 on, Apr 1st, 2021
[ 12:00 AM ] - WOPRAI
Joseph Feldman Maintained (WSM) at Buy with Increased Target to $98 on, Apr 1st, 2021
[ 12:00 AM ] - WOPRAI
Michael Sison Maintained (WLK) at Buy with Increased Target to $114 on, Apr 1st, 2021
[ 12:00 AM ] - WOPRAI
Deepak Mathivanan Initiated (WIX) at Buy and Held Target at $350 on, Apr 1st, 2021
[ 12:00 AM ] - WOPRAI
Jon Tower Maintained (WING) at Buy with Increased Target to $177 on, Apr 1st, 2021
[ 12:00 AM ] - WOPRAI
Toni Kaplan Initiated (ADV) at Hold and Held Target at $13 on, Apr 1st, 2021
[ 12:00 AM ] - WOPRAI
Tristan Gerra Initiated (AEVA) at Buy and Held Target at $100 on, Apr 1st, 2021
[ 12:00 AM ] - WOPRAI
Nigel Dally Maintained (AFL) at Buy with Increased Target to $58 on, Apr 1st, 2021
[ 12:00 AM ] - WOPRAI
Raghuram Selvaraju Maintained (BTAI) at Strong Buy with Decreased Target to $175 on, Apr 1st, 2021
[ 12:00 AM ] - WOPRAI
Robyn Karnauskas Maintained (BTAI) at Strong Buy with Decreased Target to $127 on, Apr 1st, 2021

Robyn Karnauskas Maintained (BTAI) at Strong Buy with Decreased Target to $127 on, Apr 1st, 2021


Published on 2024-10-27 16:06:05 - WOPRAI, Robyn Karnauskas
  Print publication without navigation


Robyn Karnauskas of Truist Securities, Maintained "BioXcel Therapeutics, Inc." (BTAI) at Strong Buy with Decreased Target from $150 to $127 on, Apr 1st, 2021.

Robyn has made no other calls on BTAI in the last 4 months.



There is 1 other peer that has a rating on BTAI. Out of the 1 peers that are also analyzing BTAI, 0 agree with Robyn's Rating of Hold.



This is the rating of the analyst that currently disagrees with Robyn

  • Colin Bristow of "UBS" Initiated at Strong Buy and Held Target at $99 on, Monday, February 1st, 2021
Contributing Sources